Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eulambius M. Mlugu"'
Autor:
Adam Fimbo, Yonah H. Mwalwisi, Kissa Mwamwitwa, Damas Matiko, Elirehema Mfinanga, Johnson Lyimo, Amon Sabasaba, Seth Missago, Elias Bukundi, Goodluck Gotora, Dorice Respick, Alex Nkayamba, Emmanuel Masunga, Rajabu Hussein Mnkugwe, Peter P. Kunambi, Castory Munishi, Christine Chiedza Musanhu, Omary M. S. Minzi, Eulambius M. Mlugu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Tanzania adopted a Dolutegravir (DTG)-based regimen as first-line treatment in 2019 following the World Health Organization recommendation. Data on the DTG safety profile from sub-Saharan Africa including Tanzania are limited. We investigate
Externí odkaz:
https://doaj.org/article/ea7b4164469246fb93a1c4f5c70cff76
Autor:
Adam M. Fimbo, Eulambius M. Mlugu, Eliford Ngaimisi Kitabi, Gerald S. Kulwa, Mohammed A. Iwodyah, Rajabu Hussein Mnkugwe, Peter P. Kunambi, Alpha Malishee, Appolinary A. R. Kamuhabwa, Omary M. Minzi, Eleni Aklillu
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 12, Pp 1884-1896 (2023)
Abstract Ivermectin (IVM) is a drug of choice used with albendazole for mass drug administration (MDA) to halt transmission of lymphatic filariasis. We investigated IVM pharmacokinetic (PK) variability for its dose optimization during MDA. PK samples
Externí odkaz:
https://doaj.org/article/8eb56a80061b4c679a9f5a5480a7eaf8
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction Urinary tract infection (UTI) is the second most common infectious disease affecting more than 150 million people globally annually. Uropathogenic E. coli (UPEC), the predominant cause of UTI, can occur as a biofilm associated w
Externí odkaz:
https://doaj.org/article/e29dd60bdf7f420a82e39cfc800e436a
Autor:
Wigilya P. Mikomangwa, Omary Minzi, Ritah Mutagonda, Vito Baraka, Eulambius M. Mlugu, Eleni Aklillu, Appolinary A. R. Kamuhabwa
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing
Externí odkaz:
https://doaj.org/article/7bf401209aaa4784b0904cd878e75562
Autor:
Eulambius M. Mlugu, Omary M. Minzi, Appolinary A. R. Kamuhabwa, Ulf Diczfalusy, Eleni Aklillu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 15168 (2022)
Changes in cortisol and other hormones during pregnancy may alter CYP3A enzymes activity, but data from sub-Saharan Africa are sparse. We investigated the effect of pregnancy and CYP3A5 genotypes on CYP3A enzymes activity using the plasma 4β-hydroxy
Externí odkaz:
https://doaj.org/article/8483da9377354f7ea074c8368cb3142c
Autor:
Eulambius M. Mlugu, Omary Minzi, Muhammad Asghar, Anna Färnert, Appolinary A.R. Kamuhabwa, Eleni Aklillu
Publikováno v:
Pathogens, Vol 9, Iss 3, p 207 (2020)
Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine−pyrimethamine (IPTp-SP) for prevention of malaria and adverse birth outcomes can be compromised by parasites-resistance to sulfadoxine−pyrimethamine. This study pros
Externí odkaz:
https://doaj.org/article/48d3f94baaea46a9873e422749ff6387
Autor:
Aklillu, Eulambius M. Mlugu, Omary M. Minzi, Appolinary A. R. Kamuhabwa, Ulf Diczfalusy, Eleni
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 15168
Changes in cortisol and other hormones during pregnancy may alter CYP3A enzymes activity, but data from sub-Saharan Africa are sparse. We investigated the effect of pregnancy and CYP3A5 genotypes on CYP3A enzymes activity using the plasma 4β-hydroxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::050f0a5adbc1a53eb9e2254a17e08d70
Publikováno v:
Clinical Pharmacology & Therapeutics. 110:1478-1489
Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) to prevent malaria and adverse birth outcomes is threatened by Plasmodium falciparum resistance to sulfadoxine-pyrimethamine. We investigated the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0a38486d4632b14c83c9b3bf725e60
https://doi.org/10.1002/cpt.2273
https://doi.org/10.1002/cpt.2273
Autor:
Ritah Mutagonda, Vito Baraka, Omary Minzi, Appolinary Kamuhabwa, Eulambius M. Mlugu, Wigilya P. Mikomangwa, Eleni Aklillu
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-11 (2020)
Malaria Journal
Malaria Journal
Background: Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692906bcf8e7dab2338a81be1fd08245
http://link.springer.com/article/10.1186/s12936-020-03234-4
http://link.springer.com/article/10.1186/s12936-020-03234-4
Publikováno v:
International Journal of Environmental Research and Public Health
Asymptomatic malaria and anemia during pregnancy increase the risk of negative birth outcomes. This cross-sectional study investigated the prevalence and correlates of asymptomatic malaria and anemia during first antenatal care (ANC) visit among preg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::091a51c4892ceec53c8711783b744559
https://pubmed.ncbi.nlm.nih.gov/32365839
https://pubmed.ncbi.nlm.nih.gov/32365839